Evidence map›Paper›PMID 29717770›Full record

ArticleInternational journal of molecular medicine2018

Stanozolol administration combined with exercise leads to decreased telomerase activity possibly associated with liver aging.

Eren Ozcagli, Mehtap Kara, Tugba Kotil, Persefoni Fragkiadaki, Manolis N Tzatzarakis, Christina Tsitsimpikou, Polychronis D Stivaktakis, Dimitrios Tsoukalas, Demetrios A Spandidos, Aristides M Tsatsakis and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The effect of training andAvicenna journal of phytomedicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Eren OzcagliDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Turkey.
Mehtap KaraDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Turkey.
Tugba KotilDepartment of Histology and Embryology, Faculty of Medicine, Istanbul University, Istanbul 34116, Turkey.
Persefoni FragkiadakiLaboratory of Forensic Sciences and Toxicology, Medical School, University of Crete, 71003 Heraklion, Greece.
Manolis N TzatzarakisLaboratory of Forensic Sciences and Toxicology, Medical School, University of Crete, 71003 Heraklion, Greece.
Christina TsitsimpikouGeneral Chemical State Laboratory of Greece, 11521 Athens, Greece.
Polychronis D StivaktakisLaboratory of Forensic Sciences and Toxicology, Medical School, University of Crete, 71003 Heraklion, Greece.
Dimitrios TsoukalasLaboratory of Forensic Sciences and Toxicology, Medical School, University of Crete, 71003 Heraklion, Greece.
Demetrios A SpandidosLaboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece.
Aristides M TsatsakisLaboratory of Forensic Sciences and Toxicology, Medical School, University of Crete, 71003 Heraklion, Greece.
Buket AlpertungaDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Turkey.
University of Crete · GRIstanbul University · TRGeneral Chemical State Laboratory

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anabolic agents are doping substances which are commonly used in sports. Stanozolol, a 17α‑alkylated derivative of testosterone, has a widespread use among athletes and bodybuilders. Several medical and behavioral adverse effects are associated with anabolic androgenic steroids (AAS) abuse, while the liver remains the most well recognized target organ. In the present study, the hepatic effects of stanozolol administration in rats at high doses resembling those used for doping purposes were investigated, in the presence or absence of exercise. Stanozolol and its metabolites, 16‑β‑hydroxystanozolol and 3'‑hydroxystanozolol, were detected in rat livers using liquid chromatography‑mass spectrometry (LC‑MS). Telomerase activity, which is involved in cellular aging and tumorigenesis, was detected by examining telomerase reverse transcriptase (TERT) and phosphatase and tensin homolog (PTEN) expression levels in the livers of stanozolol‑treated rats. Stanozolol induced telomerase activity at the molecular level in the liver tissue of rats and exercise reversed this induction, reflecting possible premature liver tissue aging. PTEN gene expression in the rat livers was practically unaffected either by exercise or by stanozolol administration.

Indexed as

Physical Conditioning, AnimalAgingAnimalsGene Expression RegulationImmunohistochemistryLiverMaleMetabolomePTEN PhosphohydrolaseRats, Sprague-DawleyStanozololTelomeraseTelomere3'-hydroxystanozololPTEN PhosphohydrolaseStanozololTelomerase

Identifiers

PMID29717770
PMCPMC5979936
OpenAlexW2802753970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.